Concepts (190)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vaccination | 24 | 2025 | 192 | 3.870 |
Why?
|
| Papillomavirus Vaccines | 8 | 2025 | 58 | 2.500 |
Why?
|
| Colorado | 23 | 2025 | 51 | 2.440 |
Why?
|
| Papillomavirus Infections | 5 | 2025 | 147 | 2.050 |
Why?
|
| Asthma | 4 | 2024 | 60 | 2.000 |
Why?
|
| School Health Services | 3 | 2024 | 36 | 1.880 |
Why?
|
| Refugees | 3 | 2025 | 12 | 1.620 |
Why?
|
| Obstetrics | 8 | 2022 | 51 | 1.270 |
Why?
|
| Influenza Vaccines | 10 | 2022 | 51 | 1.200 |
Why?
|
| Qualitative Research | 6 | 2025 | 200 | 1.200 |
Why?
|
| Patient Acceptance of Health Care | 5 | 2025 | 100 | 1.110 |
Why?
|
| Immunization Programs | 3 | 2025 | 15 | 1.090 |
Why?
|
| Gynecology | 6 | 2022 | 60 | 1.080 |
Why?
|
| Parents | 7 | 2025 | 131 | 1.050 |
Why?
|
| Needs Assessment | 2 | 2024 | 56 | 1.040 |
Why?
|
| Vaccination Coverage | 2 | 2025 | 13 | 0.990 |
Why?
|
| Diphtheria-Tetanus-acellular Pertussis Vaccines | 7 | 2022 | 16 | 0.930 |
Why?
|
| Motivational Interviewing | 2 | 2022 | 9 | 0.870 |
Why?
|
| Child | 12 | 2025 | 2271 | 0.840 |
Why?
|
| Social Determinants of Health | 1 | 2024 | 37 | 0.820 |
Why?
|
| Practice Patterns, Physicians' | 4 | 2019 | 164 | 0.800 |
Why?
|
| Prenatal Care | 2 | 2020 | 41 | 0.790 |
Why?
|
| Humans | 41 | 2025 | 28585 | 0.770 |
Why?
|
| Female | 32 | 2025 | 15472 | 0.770 |
Why?
|
| Health Services Research | 2 | 2019 | 43 | 0.770 |
Why?
|
| Community Participation | 2 | 2021 | 27 | 0.720 |
Why?
|
| Private Practice | 1 | 2020 | 8 | 0.690 |
Why?
|
| Stakeholder Participation | 1 | 2020 | 7 | 0.680 |
Why?
|
| Health Knowledge, Attitudes, Practice | 8 | 2021 | 301 | 0.680 |
Why?
|
| Mothers | 7 | 2022 | 124 | 0.660 |
Why?
|
| Pregnancy | 16 | 2022 | 1219 | 0.640 |
Why?
|
| Adolescent | 11 | 2025 | 3165 | 0.640 |
Why?
|
| Patient Outcome Assessment | 1 | 2019 | 14 | 0.620 |
Why?
|
| Documentation | 1 | 2019 | 27 | 0.610 |
Why?
|
| Electronic Health Records | 1 | 2019 | 63 | 0.590 |
Why?
|
| Influenza, Human | 5 | 2022 | 92 | 0.580 |
Why?
|
| Pediatrics | 1 | 2019 | 92 | 0.580 |
Why?
|
| Human Development | 1 | 2018 | 4 | 0.570 |
Why?
|
| Whooping Cough | 5 | 2022 | 15 | 0.550 |
Why?
|
| Learning | 1 | 2018 | 99 | 0.530 |
Why?
|
| Male | 13 | 2025 | 13772 | 0.490 |
Why?
|
| Young Adult | 8 | 2024 | 2804 | 0.480 |
Why?
|
| Students | 1 | 2018 | 199 | 0.480 |
Why?
|
| Pregnant Women | 7 | 2022 | 23 | 0.480 |
Why?
|
| Infant | 11 | 2025 | 1019 | 0.450 |
Why?
|
| Patient Education as Topic | 3 | 2020 | 91 | 0.440 |
Why?
|
| Adult | 15 | 2024 | 7922 | 0.400 |
Why?
|
| Community-Based Participatory Research | 2 | 2025 | 37 | 0.380 |
Why?
|
| Interviews as Topic | 2 | 2024 | 160 | 0.350 |
Why?
|
| Vaccines | 2 | 2022 | 35 | 0.350 |
Why?
|
| Diphtheria | 3 | 2022 | 4 | 0.350 |
Why?
|
| Tetanus | 3 | 2022 | 5 | 0.340 |
Why?
|
| Attitude of Health Personnel | 2 | 2025 | 149 | 0.330 |
Why?
|
| Mass Screening | 2 | 2024 | 156 | 0.310 |
Why?
|
| Ambulatory Care | 2 | 2019 | 60 | 0.310 |
Why?
|
| Attitude to Health | 3 | 2020 | 89 | 0.300 |
Why?
|
| Health Services Accessibility | 3 | 2025 | 116 | 0.300 |
Why?
|
| Mobile Applications | 2 | 2020 | 67 | 0.300 |
Why?
|
| Immunization | 4 | 2022 | 121 | 0.290 |
Why?
|
| Surveys and Questionnaires | 7 | 2021 | 994 | 0.280 |
Why?
|
| Rural Health Services | 2 | 2025 | 25 | 0.270 |
Why?
|
| Primary Health Care | 2 | 2020 | 160 | 0.260 |
Why?
|
| Antipsychotic Agents | 2 | 2016 | 24 | 0.240 |
Why?
|
| Medicaid | 2 | 2016 | 55 | 0.240 |
Why?
|
| Models, Economic | 1 | 2025 | 8 | 0.240 |
Why?
|
| Housing | 1 | 2025 | 24 | 0.230 |
Why?
|
| Infant, Newborn | 4 | 2025 | 899 | 0.230 |
Why?
|
| Blood Glucose | 2 | 2016 | 310 | 0.220 |
Why?
|
| Health Personnel | 1 | 2025 | 96 | 0.220 |
Why?
|
| Palliative Care | 1 | 2025 | 84 | 0.220 |
Why?
|
| Delphi Technique | 1 | 2024 | 23 | 0.220 |
Why?
|
| Research Design | 2 | 2022 | 185 | 0.210 |
Why?
|
| Emergency Service, Hospital | 1 | 2025 | 121 | 0.210 |
Why?
|
| Delivery of Health Care | 2 | 2022 | 118 | 0.210 |
Why?
|
| Databases, Factual | 1 | 2025 | 265 | 0.210 |
Why?
|
| Georgia | 5 | 2021 | 22 | 0.210 |
Why?
|
| Neoplasms | 2 | 2025 | 857 | 0.200 |
Why?
|
| Case-Control Studies | 1 | 2025 | 732 | 0.200 |
Why?
|
| Immunization Schedule | 2 | 2019 | 13 | 0.190 |
Why?
|
| Intention | 2 | 2020 | 78 | 0.190 |
Why?
|
| Pilot Projects | 1 | 2024 | 458 | 0.190 |
Why?
|
| Research Personnel | 1 | 2022 | 39 | 0.180 |
Why?
|
| Quality Improvement | 2 | 2020 | 123 | 0.180 |
Why?
|
| Language | 1 | 2022 | 65 | 0.180 |
Why?
|
| Ambulatory Care Facilities | 2 | 2019 | 54 | 0.180 |
Why?
|
| Policy Making | 1 | 2021 | 13 | 0.180 |
Why?
|
| Bhutan | 1 | 2020 | 2 | 0.170 |
Why?
|
| Alphapapillomavirus | 1 | 2020 | 8 | 0.160 |
Why?
|
| Child Health | 1 | 2019 | 17 | 0.150 |
Why?
|
| Health Care Surveys | 1 | 2019 | 67 | 0.150 |
Why?
|
| Aged | 3 | 2025 | 5525 | 0.150 |
Why?
|
| Middle Aged | 4 | 2025 | 7310 | 0.150 |
Why?
|
| Patient Participation | 1 | 2019 | 56 | 0.150 |
Why?
|
| Patient Compliance | 1 | 2019 | 76 | 0.150 |
Why?
|
| Parenting | 1 | 2019 | 56 | 0.150 |
Why?
|
| Carbon | 2 | 2012 | 107 | 0.150 |
Why?
|
| Communication | 1 | 2020 | 179 | 0.150 |
Why?
|
| Information Seeking Behavior | 1 | 2018 | 14 | 0.150 |
Why?
|
| Family Relations | 1 | 2018 | 11 | 0.140 |
Why?
|
| Decision Making | 1 | 2019 | 177 | 0.140 |
Why?
|
| Universities | 1 | 2018 | 124 | 0.130 |
Why?
|
| United States | 5 | 2025 | 2201 | 0.130 |
Why?
|
| Standing Orders | 1 | 2016 | 1 | 0.130 |
Why?
|
| Amyloid Precursor Protein Secretases | 2 | 2007 | 25 | 0.130 |
Why?
|
| State Health Plans | 1 | 2016 | 3 | 0.130 |
Why?
|
| Bipolar Disorder | 1 | 2016 | 41 | 0.120 |
Why?
|
| Community Mental Health Services | 1 | 2016 | 16 | 0.120 |
Why?
|
| Drug Prescriptions | 1 | 2016 | 46 | 0.120 |
Why?
|
| Schizophrenia | 1 | 2016 | 49 | 0.120 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2015 | 13 | 0.120 |
Why?
|
| Lipids | 1 | 2016 | 214 | 0.110 |
Why?
|
| Health Promotion | 1 | 2015 | 177 | 0.100 |
Why?
|
| Diabetes Mellitus | 1 | 2016 | 215 | 0.100 |
Why?
|
| Age Factors | 1 | 2015 | 734 | 0.100 |
Why?
|
| Rural Population | 2 | 2025 | 120 | 0.090 |
Why?
|
| Hydro-Lyases | 1 | 2012 | 8 | 0.090 |
Why?
|
| Lignin | 1 | 2012 | 17 | 0.090 |
Why?
|
| Pertussis Vaccine | 2 | 2022 | 6 | 0.080 |
Why?
|
| Alkenes | 2 | 2006 | 15 | 0.080 |
Why?
|
| Child, Preschool | 2 | 2025 | 1167 | 0.070 |
Why?
|
| Sulfur | 1 | 2007 | 35 | 0.070 |
Why?
|
| Protease Inhibitors | 1 | 2007 | 40 | 0.070 |
Why?
|
| Missouri | 2 | 2016 | 9 | 0.060 |
Why?
|
| Hydrocarbons, Aromatic | 1 | 2006 | 9 | 0.060 |
Why?
|
| Nitriles | 1 | 2006 | 33 | 0.060 |
Why?
|
| Oxides | 1 | 2006 | 14 | 0.060 |
Why?
|
| Life Expectancy | 1 | 2025 | 23 | 0.060 |
Why?
|
| Drug Overdose | 1 | 2025 | 11 | 0.060 |
Why?
|
| Cost-Benefit Analysis | 1 | 2025 | 114 | 0.060 |
Why?
|
| Enzyme Inhibitors | 1 | 2006 | 251 | 0.060 |
Why?
|
| Focus Groups | 1 | 2025 | 101 | 0.060 |
Why?
|
| Referral and Consultation | 1 | 2025 | 98 | 0.060 |
Why?
|
| Retrospective Studies | 2 | 2025 | 2612 | 0.050 |
Why?
|
| Emergency Medical Services | 1 | 2025 | 81 | 0.050 |
Why?
|
| Vulnerable Populations | 1 | 2024 | 48 | 0.050 |
Why?
|
| HIV Infections | 1 | 2025 | 161 | 0.050 |
Why?
|
| Substance-Related Disorders | 1 | 2025 | 187 | 0.050 |
Why?
|
| Schools | 1 | 2022 | 83 | 0.040 |
Why?
|
| Social Networking | 1 | 2020 | 10 | 0.040 |
Why?
|
| Vaccination Refusal | 1 | 2019 | 2 | 0.040 |
Why?
|
| Psychometrics | 1 | 2019 | 122 | 0.040 |
Why?
|
| Patient Satisfaction | 1 | 2019 | 96 | 0.040 |
Why?
|
| Pediatricians | 1 | 2018 | 4 | 0.040 |
Why?
|
| Urban Health Services | 1 | 2018 | 8 | 0.040 |
Why?
|
| Models, Theoretical | 1 | 2019 | 134 | 0.040 |
Why?
|
| Internet | 1 | 2019 | 126 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 2019 | 251 | 0.040 |
Why?
|
| Postpartum Period | 1 | 2018 | 72 | 0.040 |
Why?
|
| Health Behavior | 1 | 2019 | 158 | 0.030 |
Why?
|
| Physician Executives | 1 | 2016 | 5 | 0.030 |
Why?
|
| Stereoisomerism | 2 | 2007 | 45 | 0.030 |
Why?
|
| Administrative Personnel | 1 | 2016 | 7 | 0.030 |
Why?
|
| Allied Health Personnel | 1 | 2016 | 14 | 0.030 |
Why?
|
| Nurses | 1 | 2016 | 13 | 0.030 |
Why?
|
| Patient Preference | 1 | 2016 | 33 | 0.030 |
Why?
|
| Diphtheria Toxoid | 1 | 2015 | 1 | 0.030 |
Why?
|
| Tetanus Toxoid | 1 | 2015 | 5 | 0.030 |
Why?
|
| Molecular Structure | 2 | 2007 | 244 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2016 | 190 | 0.030 |
Why?
|
| Evidence-Based Practice | 1 | 2015 | 31 | 0.030 |
Why?
|
| Social Behavior | 1 | 2015 | 54 | 0.030 |
Why?
|
| Risk | 1 | 2015 | 137 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2016 | 146 | 0.030 |
Why?
|
| Time Factors | 1 | 2018 | 1600 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 389 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2016 | 622 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2016 | 893 | 0.030 |
Why?
|
| Chloroplasts | 1 | 2012 | 4 | 0.020 |
Why?
|
| Glucuronidase | 1 | 2012 | 9 | 0.020 |
Why?
|
| Gene Knockout Techniques | 1 | 2012 | 36 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2015 | 988 | 0.020 |
Why?
|
| Acetates | 1 | 2012 | 45 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2012 | 86 | 0.020 |
Why?
|
| Gene Expression Regulation, Plant | 1 | 2012 | 74 | 0.020 |
Why?
|
| Protein Transport | 1 | 2012 | 158 | 0.020 |
Why?
|
| Arabidopsis | 1 | 2012 | 68 | 0.020 |
Why?
|
| Phenotype | 1 | 2012 | 682 | 0.020 |
Why?
|
| Keto Acids | 1 | 2007 | 3 | 0.020 |
Why?
|
| Fluorine | 1 | 2007 | 5 | 0.020 |
Why?
|
| Crystallization | 1 | 2007 | 50 | 0.020 |
Why?
|
| Magnesium | 1 | 2007 | 42 | 0.020 |
Why?
|
| Solubility | 1 | 2007 | 73 | 0.020 |
Why?
|
| Sulfides | 1 | 2007 | 40 | 0.020 |
Why?
|
| Amino Alcohols | 1 | 2006 | 3 | 0.020 |
Why?
|
| Tartrates | 1 | 2006 | 2 | 0.020 |
Why?
|
| Sulfones | 1 | 2006 | 7 | 0.020 |
Why?
|
| Temperature | 1 | 2007 | 213 | 0.020 |
Why?
|
| Molecular Conformation | 1 | 2006 | 67 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2007 | 366 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2006 | 222 | 0.010 |
Why?
|